Walden Group Healthcare M&A Blog

  • Werfen Group Buys Immucor for $2b

    3/29/2023
    Spain-based manufacturer and distributor of diagnostic instruments Werfen has acquired Immucor, a manufacturer of transfusion and transplant diagnostic devices.  The acquisition adds platelet detection, diagnostic analyzers, blood monitoring and molecular testing products that help match patients and donors.  Deal terms -- $2b. Keywords:...
    Read More
  • The Walden Group Releases 2022 Year-End Strategic Healthcare M&A Report

    3/10/2023
    The Walden Group is pleased to provide access to its Q4 2022 Strategic Healthcare M&A Report, which includes:       Recent Divestitures and Spin-Offs     Diagnostic and Medical Device Deals with Valuations over $100m     Noteworthy M&A Deals By Sector     Top Deals > $100m in Transaction Value Announced or Closed in 2022  ...
    Read More
  • Shockwave Medical to Acquire Neovasc for $100m

    2/7/2023
    Shockwave Medical, a $237m developer of technologies treating calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve disease, is acquiring Neovasc, a $2.5m Canada-based developer of transcatheter devices treating refractory angina and mitral valve disease.  Deal terms – $100m upfront plus $47m in milestones...
    Read More
  • Zimmer Biomet Acquires Embody for $150m

    1/9/2023
    Zimmer Biomet Holdings, Inc., a $8.0b maker of orthopedic reconstructive products is acquiring Embody, Inc., a developer of collagen implants for repairing tendons, ligaments and torn rotator cuffs.  The acquisition builds Zimmer Biomet’s sports medicine offerings after it spun-off its dental and spine operations into Zimvie, a separate,...
    Read More
  • The Walden Group Represented Total Titanium, Inc in Its Sale to a Subsidiary of Bausch + Lomb Corporation

    12/21/2022
    The Walden Group is pleased to announce that it represented Total Titanium, Inc. (TTI) in its sale to a subsidiary of Bausch + Lomb Corporation (NYSE/TSX:BLCO) (“Bausch + Lomb”). TTI was one of the last remaining independently-owned manufacturers of precision ophthalmic instruments based in the United States. Bausch + Lomb is a leading global...
    Read More